Technical Analysis for EKF - Ekf Diagnostics Holdings Plc

Grade Last Price % Change Price Change
F 27.65 3.16% 0.85
EKF closed up 2.68 percent on Wednesday, March 27, 2024, on 73 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 3.16%
MACD Bullish Signal Line Cross Bullish 3.16%
Calm After Storm Range Contraction 3.16%
Doji - Bearish? Reversal 3.16%
Earnings Movers Other 3.16%
Gapped Up Strength 3.16%
Calm After Storm Range Contraction 5.93%
Earnings Movers Other 5.93%
Outside Day Range Expansion 5.93%
New Downtrend Bearish 4.33%

   Recent Intraday Alerts

Alert Time
Up 3% about 2 hours ago
Rose Above Previous Day's High about 5 hours ago
20 DMA Resistance about 6 hours ago
20 DMA Support about 7 hours ago
3x Volume Pace about 7 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ekf Diagnostics Holdings Plc Description

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Manufacturing Medicine Science Life Sciences Disease Monitoring Clinical Medicine Diseases Infectious Diseases Infectious Disease Biomarker Beta Diabetes Enzymes Infectious Ancillary Products Medical Tests Blood Tests Ekf Ekf Diagnostics

Is EKF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 38.2051
52 Week Low 22.4007
Average Volume 261,022
200-Day Moving Average 28.42
50-Day Moving Average 28.46
20-Day Moving Average 26.79
10-Day Moving Average 26.13
Average True Range 1.47
RSI (14) 48.45
ADX 26.42
+DI 12.94
-DI 21.88
Chandelier Exit (Long, 3 ATRs) 24.28
Chandelier Exit (Short, 3 ATRs) 27.62
Upper Bollinger Bands 28.72
Lower Bollinger Band 24.87
Percent B (%b) 0.5
BandWidth 14.38
MACD Line -0.63
MACD Signal Line -0.70
MACD Histogram 0.0678
Fundamentals Value
Market Cap 121.6 Million
Num Shares 454 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -893.33
Price-to-Sales 2.34
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.01
Dividend Yield 0.04%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.74
Resistance 3 (R3) 28.72 28.06 28.41
Resistance 2 (R2) 28.06 27.57 28.07 28.30
Resistance 1 (R1) 27.43 27.26 27.10 27.45 28.20
Pivot Point 26.77 26.77 26.61 26.78 26.77
Support 1 (S1) 26.14 26.28 25.81 26.16 25.40
Support 2 (S2) 25.48 25.97 25.49 25.30
Support 3 (S3) 24.85 25.48 25.19
Support 4 (S4) 24.87